# MolecularMD Corp – FDA 483, May 29, 2026

Source: https://www.keypedia.com/records/483/molecularmd-corp/e4ae622d-164c-4f38-ad31-5cf06a5ea6e3

> FDA 483 for MolecularMD Corp on May 29, 2026. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: MolecularMD Corp
- Inspection Date: 2026-05-29
- Product Type: device
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: An FDA inspection of MolecularMD Corp in Portland, OR, revealed significant deficiencies in their quality management system. The firm failed to conduct adequate management reviews and internal audits for extended periods, and critical medical device suppliers were not properly monitored or re-evaluated. These observations indicate a systemic breakdown in maintaining essential quality controls.

## Related Officers

- [Investigator](https://www.keypedia.com/people/alexandria-l-capuano/f76c710a-613f-42b2-8958-1292fa329112)
- [Richard E. Evoy](https://www.keypedia.com/people/richard-e-evoy/31c4827c-e0dc-4ddf-b516-714209b2515d)

Company: https://www.keypedia.com/companies/molecularmd-corp/bf304461-b7e3-49fa-a801-b5c28176078a

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822